0
0 (0%)
Accustem Sciences Inc. [ACUT]
Source:
Company Overview
Accustem Sciences Inc. is a clinical stage diagnostics company dedicated to improving quality of life and outcomes for the more than 18 million people worldwide who are diagnosed with cancer each year. Our plan is to develop and commercialize a suite of novel genomic tests that support decision making along the entire continuum of oncology care.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | 00 44 2074952379 |
| Industry | manufacturing |
| CEO | Wendy Blosser |
| Website | AccuStem.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-1.5 |
| Net Income | $-1.5 |
| Net Cash | $-0 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -1,629.4% |
| Profit as % of Stockholder Equity | 45.4% |
Management Effectiveness
| Return on Equity | 45.4% |
| Return on Assets | -2,959.8% |
| Turnover Ratio | |
| EBITA | $-1.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $0.1 |
| Total Liabilities | $3.4 |
| Operating Cash Flow | $-0.7 |
| Investing Cash Flow | |
| Financing Cash Flow | $0.6 |
